News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Neil Schneider, ASA, MAAA

Articles by Neil Schneider, ASA, MAAA

Third-Party Validation of Observed Savings From an Oncology Pathways Program

ByBruce A. Feinberg, DO,Scott Milligan, PhD,Joseph Cooper, BS,Winston Wong, PharmD,Daniel Winn, MD,Neil Schneider, ASA, MAAA,Sheamus Parkes, FSA, MAAA,Jeffrey Scott, MD

June 18th 2013

Latest Updated Articles

Third-Party Validation of Observed Savings From an Oncology Pathways Program
Published: June 18th 2013 | Updated:

Trending on AJMC

NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes

Detailed Liver Atlas Links Macrophage Activity to MASH Progression

CheckMate 9LA at 6 Years Shows Enduring Benefits From Dual Immunotherapy Plus Chemotherapy in Metastatic NSCLC

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.